{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:31Z","timestamp":1791389011624,"version":"4.3.3"},"reference-count":31,"publisher":"Informa UK Limited","issue":"12","funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Asthma"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1080\/02770903.2024.2380520","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T11:26:32Z","timestamp":1721042792000},"page":"1746-1758","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Patient and clinician preferences for biologic treatments for severe uncontrolled asthma: a discrete choice experiment (DCE)"],"prefix":"10.1080","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7317-9273","authenticated-orcid":false,"given":"Melissa M.","family":"Ross","sequence":"first","affiliation":[{"name":"Evidera Inc., Wilmington, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen","family":"Chung","sequence":"additional","affiliation":[{"name":"AstraZeneca, Wilmington, DE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Carr","sequence":"additional","affiliation":[{"name":"Asthma and Airways Disease Research Center, University of AZ, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Ambrose","sequence":"additional","affiliation":[{"name":"AstraZeneca, Wilmington, DE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Lindsley","sequence":"additional","affiliation":[{"name":"Amgen, Thousand Oaks, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Collacott","sequence":"additional","affiliation":[{"name":"Evidera Inc., Wilmington, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schulz","sequence":"additional","affiliation":[{"name":"Evidera Inc., Wilmington, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Desai","sequence":"additional","affiliation":[{"name":"Novartis, East Hanover, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Rane","sequence":"additional","affiliation":[{"name":"Amgen, Thousand Oaks, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Williams","sequence":"additional","affiliation":[{"name":"Northern VA Pulmonary and Critical Care Associates PC, Annadale, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Gelhorn","sequence":"additional","affiliation":[{"name":"Evidera Inc., Wilmington, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,8]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention 2017. Available from: https:\/\/ginasthma.org\/wp-content\/uploads\/2019\/04\/wmsGINA-2017-main-report-final_V2.pdf [last accessed 25 March 2021]."},{"key":"e_1_3_4_3_1","unstructured":"Center for Disease Control and Prevention (CDC). Most Recent National Asthma Data 2022. Available from: https:\/\/www.cdc.gov\/asthma\/most_recent_national_asthma_data.htm [last accessed 25 March 2022]."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S327659"},{"key":"e_1_3_4_5_1","unstructured":"Difficult-to-Treat & Severe Asthma in Adolescent and Adult Patients. Global Initiative for Asthma (GINA); 2023. Available from: https:\/\/ginasthma.org\/wp-content\/uploads\/2023\/09\/GINA-Severe-Asthma-Guide-2023-WEB-WMS.pdf."},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.08.024"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-018-0151-5"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034975"},{"key":"e_1_3_4_9_1","unstructured":"American Academy of Allergy Asthma & Immunology (AAAAI). Biologics for the Management of Severe Asthma 2019. Available from: https:\/\/www.aaaai.org\/conditions-and-treatments\/library\/asthma-library\/biologics-asthma [last accessed 25 March 2021]."},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-017-0219-4"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-022-00676-0"},{"key":"e_1_3_4_12_1","unstructured":"Food and Drug Administration (FDA). FDA approves maintenance treatment for severe asthma 2021. Available from: https:\/\/www.fda.gov\/media\/92593\/ [last accessed 20 June 2023]."},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.2007.3.1.167"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2009.30.3205"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-214343"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-007-0075-0"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S365117"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0734-2"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7248.1530"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826080-00004"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/01441640902827623"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.11.013"},{"key":"e_1_3_4_23_1","unstructured":"Food and Drug Administration (FDA). Patient preference information: voluntary submission review in premarket approval applications humanitarian device exemption applications and de novo requests and inclusion in decision summaries and device labeling. Guidance for industry Food and Drug Administration staff and other stakeholders 2016. Available from: https:\/\/www.fda.gov\/media\/92593\/ [last accessed 10 August 2022]."},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.02.042"},{"issue":"8","key":"e_1_3_4_25_1","first-page":"588","article-title":"Brief questions to identify patients with inadequate health literacy","volume":"36","author":"Chew LD","year":"2004","unstructured":"Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36(8):588\u2013594.","journal-title":"Fam Med"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0520-5"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/10810730.2011.604383"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X0102100105"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.2307\/1924536"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020909529486"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.07.876"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.04.1924"}],"container-title":["Journal of Asthma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02770903.2024.2380520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T05:27:45Z","timestamp":1732080465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02770903.2024.2380520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1080\/02770903.2024.2380520"],"URL":"https:\/\/doi.org\/10.1080\/02770903.2024.2380520","relation":{},"ISSN":["0277-0903","1532-4303"],"issn-type":[{"value":"0277-0903","type":"print"},{"value":"1532-4303","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijas20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijas20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-01-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}